StockData

Aquestive Therapeutics vs Rockwell Medical

AQST and RMTI side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AQST and RMTI compare

Aquestive Therapeutics is the larger company, worth 17 times as much as Rockwell Medical ($464M against $26.6M).

Aquestive Therapeutics grew revenue faster over the last twelve months (22.6% versus −21.1% for Rockwell Medical).

Rockwell Medical keeps more of each dollar of sales as profit, with a net margin of −7.3% compared with −145% at Aquestive Therapeutics.

Rockwell Medical scores higher on the StockData Score (11 against 3 for Aquestive Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAQSTRMTI
Size and price
Market cap$464M$26.6M
Share price$3.70$6.61
Change, 1 year−31.4%−28.1%
Change, 5 years−41.9%−86.3%
Beta (5Y)1.200.01
Employees147157
StockData Score
Total score311 (better)
Valuation score03 (better)
Growth score2 (better)1
Performance score03 (better)
Health score14 (better)
Dividend score00
Valuation
P/S8.6×0.4× (better)
P/B–0.8×
P/FCF–17.3×
FCF yield−9.9%5.8% (better)
Fair value–$32.27
Margin of safety–79.5%
Growth
Revenue growth (TTM)22.6% (better)−21.1%
Revenue growth, 5Y average−0.58%2.2% (better)
Profitability
Gross margin67.0% (better)17.7%
Operating margin−97.5%−6.5% (better)
Net margin−145%−7.3% (better)
FCF margin−85.0%2.2% (better)
Return on equity–−15.5%
Return on invested capital–−17.9%
Financial health
Debt / equity–0.26
Interest coverage−4.7×−4.0× (better)
Current ratio7.19 (better)3.25
Altman Z-score−3.57 (better)−7.81
Piotroski F-score22
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions57.4%0.05%
Held by insiders3.2%100%
Insider net buying, 12 months−$2.3M−$11.6K (better)
Short interest, % of float24.1%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.